Expert Council for Special Economic Zones of Technical Innovation Type approved the project by ZAO Tomsk Cell Technology

11.01.2012

Cell Technology Development Center intends to set up Tomsk Cell Technology company (TCT) in the Tomsk SEZ.
This innovative organization was created in 2007 by the Tomsk Regional Venture Fund and the technology development group under the project "Development of autogenous vaccines for the treatment of tuberculosis and oncological diseases (lung cancer, gastric cancer, colorectal cancer)". Since then, the company has made some achievements. It has conducted clinical studies on immune recovery in patients with pulmonary tuberculosis which showed that conventional treatment methods in combination with the developed autogenous vaccine prove effective both for the treatment of drug-resistant and drug-sensitive tuberculosis. Currently, the permit for the implementation of a new medical technology is being obtained.
ZAO TCT will work in the Tomsk SEZ on the development of autogenous vaccines based on autologous dendritic cells used in the treatment of various oncological and infectious diseases.

Source: Tomsk Region Administration Information Server
Printable version

You can mark you interesting snippets of text that will be available through a unique link in your browser.